Table 1 Clinico-pathological parameters (percentages in brackets) and protein expression of B- and L-FABP in renal cell carcinomas.
From: Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
| Â | Â | Total | B-FABP positive | L-FABP positive |
|---|---|---|---|---|
All cases | Â | 272 (100) | 141 (51.8) | 83 (30.5) |
Age |  | 29 – 88 |  |  |
mean | Â | 63.7 | Â | Â |
Histology | Clear cell | 224 (82.4) | 123 (54.9) | 69 (30.8) |
| Â | Papillary | 37 (13.6) | 11 (29.7) | 10 (27.0) |
| Â | Chromophobe | 11 (4.0) | 7 (63.4) | 4 (36.4) |
Fuhrman Grading | G1 | 4 (1.5) | 3 (75.0) | 1 (25.0) |
| Â | G2 | 87 (31.9) | 44 (50.6) | 29 (33.3) |
| Â | G3 | 114 (42.0) | 63 (55.3) | 34 (29.8) |
| Â | G4 | 67 (24.6) | 31 (46.3) | 19 (28.3) |
pT status | pT1 | 112 (41.2) | 58 (51.8) | 38 (33.9) |
| Â | pT2 | 35 (12.9) | 16 (45.7) | 7 (20.0) |
| Â | pT3 | 120 (44.1) | 62 (51.7) | 37 (30.8) |
| Â | pT4 | 5 (1.8) | 5 (100) | 1 (20.0) |
Metastasis | M0 | 96 (35.3) | 49 (51.0) | 32 (33.3) |
| Â | M1 | 42 (15.4) | 24 (57.1) | 9 (21.4) |
| Â | X | 134 (49.3) | 68 (50.7) | 42 (31.3) |